Citation Impact
Citing Papers
Update on Meningococcal Disease with Emphasis on Pathogenesis and Clinical Management
2000
Inducible costimulator is required for type 2 antibody isotype switching but not T helper cell type 2 responses in chronic nematode infection
2005 StandoutNobel
Epidemiology of Invasive Candidiasis: a Persistent Public Health Problem
2007 Standout
Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance
2018 Standout
Improvement of a Potential Anthrax Therapeutic by Computational Protein Design
2011 StandoutNobel
VaxiJen: a server for prediction of protective antigens, tumour antigens and subunit vaccines
2007 Standout
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease
2007 Standout
Lipid-nanoparticle-encapsulated mRNA vaccines induce protective memory CD8 T cells against a lethal viral infection
2021 StandoutNobel
Messenger RNA-Based Vaccines Against Infectious Diseases
2020 StandoutNobel
Elements of cancer immunity and the cancer–immune set point
2017 StandoutNature
Streptococcus pneumoniaeProtein Vaccine Candidates: Properties, Activities and Animal Studies
2006
Practice Guidelines for the Management of Community-Acquired Pneumonia in Adults
2000 Standout
B1b Lymphocytes Confer T Cell-Independent Long-Lasting Immunity
2004 StandoutNobel
mRNA vaccines — a new era in vaccinology
2018 StandoutNobel
The microbiota in adaptive immune homeostasis and disease
2016 StandoutNature
Longitudinal transcriptomic characterization of the immune response to acute hepatitis C virus infection in patients with spontaneous viral clearance
2018 StandoutNobel
Biofilms: the matrix revisited
2004 Standout
Immunologic correlates of protection induced by vaccination
2001
Lipid nanoparticles for mRNA delivery
2021 Standout
Vaccines: Correlates of Vaccine‐Induced Immunity
2008
A Randomized, Double‐Blind, Placebo‐Controlled Trial to Evaluate the Prime‐Boost Strategy for Pneumococcal Vaccination in Adult Liver Transplant Recipients
2008
Ultrasensitive Antibody Detection by Agglutination-PCR (ADAP)
2016 StandoutNobel
Comparison of antibody kinetics following meningococcal serogroup C conjugate vaccine between healthy adults previously vaccinated with meningococcal A/C polysaccharide vaccine and vaccine-naıve controls
2001
Crystal Structure of Neisserial Surface Protein A (NspA), a Conserved Outer Membrane Protein with Vaccine Potential
2003
Limited efficacy of inactivated influenza vaccine in elderly individuals is associated with decreased production of vaccine-specific antibodies
2011
Juvenile idiopathic arthritis
2007 Standout
Long term effects of vaccination of patients deficient in a late complement component with a tetravalent meningococcal polysaccharide vaccine
2003
The Diagnosis and Management of Acute Otitis Media
2013 Standout
Streptococcus pneumoniae colonisation: the key to pneumococcal disease
2004 Standout
Correlates of immunity for pneumococcal conjugate vaccines
2003
Pilot trial of a pentavalent pneumococcal polysaccharide/protein conjugate vaccine in Gambian infants
1996
Antibody blocks acquisition of bacterial colonization through agglutination
2014
mRNA vaccines for infectious diseases: principles, delivery and clinical translation
2021 StandoutNobel
Role of the Microbiota in Immunity and Inflammation
2014 Standout
Neonatal and early life vaccinology
2001
Causes, consequences, and reversal of immune system aging
2013
Molecular signatures of antibody responses derived from a systems biology study of five human vaccines
2013
Inhibition of Pneumococcal Carriage in Mice by Subcutaneous Immunization with Peptides from the Common Surface Protein Pneumococcal Surface Adhesin A
2002
Validation of a routine opsonophagocytosis assay to predict invasive pneumococcal disease efficacy of conjugate vaccine in children
2006
Heterogeneous in vivo expression of clumping factor A and capsular polysaccharide by Staphylococcus aureus: Implications for vaccine design
2009
Physiological heterogeneity in biofilms
2008 Standout
MAST: a flexible statistical framework for assessing transcriptional changes and characterizing heterogeneity in single-cell RNA sequencing data
2015 Standout
Confronting the pneumococcus: a target shift or bullet change?
2000
Reverse vaccinology: a genome-based approach for vaccine development
2002
Immunogenicity of a Reduced Schedule of Pneumococcal Conjugate Vaccine in Healthy Infants and Correlates of Protection for Serotype 6B in the United Kingdom
2010
Sustained Reductions in Invasive Pneumococcal Disease in the Era of Conjugate Vaccine
2009 Standout
Meningococcal C Polysaccharide Vaccine Induces Immunologic Hyporesponsiveness in Adults That Is Overcome by Meningococcal C Conjugate Vaccine
2000
Dendritic Cells
1999
Meningococcal Disease
2001
Stress-induced immune dysfunction: implications for health
2005 Standout
Safety and efficacy of meningococcal c vaccination in juvenile idiopathic arthritis
2007
Innate immunity of the newborn: basic mechanisms and clinical correlates
2007 Standout
Novel vaccine strategies to T-independent antigens
2001
Randomized, Double‐Blind, Controlled Trial of Pneumococcal Vaccination in Renal Transplant Recipients
2003
The Meningococcal Vaccine — Public Policy and Individual Choices
2003
Heterologous Epitope-Scaffold Prime∶Boosting Immuno-Focuses B Cell Responses to the HIV-1 gp41 2F5 Neutralization Determinant
2011 StandoutNobel
Efficacy of a Pneumococcal Conjugate Vaccine against Acute Otitis Media
2001 Standout
The Nature of Small-Airway Obstruction in Chronic Obstructive Pulmonary Disease
2004 Standout
Immunological responses to pneumococcal vaccine in frail older people
2008
Immunogenicity and protective efficacy induced by self-amplifying mRNA vaccines encoding bacterial antigens
2016
Disordered Microbial Communities in Asthmatic Airways
2010 Standout
Guidelines for the management of adult lower respiratory tract infections
2005
Frailty in elderly people
2013 Standout
Quantitative and Qualitative Anamnestic Immune Responses to Pneumococcal Conjugate Vaccine in HIV‐Infected and HIV‐Uninfected Children 5 Years after Vaccination
2009
Vaccine review: “Staphyloccocus aureus vaccines: Problems and prospects”
2013
Bacteremic and Nonbacteremic Pneumococcal Pneumonia A Prospective Study
2000
The human skin microbiome
2018 Standout
Antibody Responses in Postsplenectomy Trauma Patients Receiving the 23-Valent Pneumococcal Polysaccharide Vaccine at 14 versus 28 Days Postoperatively
2002
Imbalanced Host Response to SARS-CoV-2 Drives Development of COVID-19
2020 Standout
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease
2012 Standout
Immunization with HIV Gag targeted to dendritic cells followed by recombinant New York vaccinia virus induces robust T-cell immunity in nonhuman primates
2011 StandoutNobel
10-valent pneumococcal nontypeableHaemophilus influenzaePD conjugate vaccine: Synflorix™
2009
Bacterial Infection in Chronic Obstructive Pulmonary Disease in 2000: a State-of-the-Art Review
2001
Enhanced SARS-CoV-2 neutralization by dimeric IgA
2020 StandoutNobel
Poly-γ-Glutamate Capsule-Degrading Enzyme Treatment Enhances Phagocytosis and Killing of EncapsulatedBacillus anthracis
2006
Avidity as a Determinant of the Protective Efficacy of Human Antibodies to Pneumococcal Capsular Polysaccharides
1999
Pathogen Recognition and Inflammatory Signaling in Innate Immune Defenses
2009 Standout
Protection against meningococcal serogroup ACYW disease in complement-deficient individuals vaccinated with the tetravalent meningococcal capsular polysaccharide vaccine
1998
Dysregulated inflammation as a risk factor for pneumonia in the elderly.
2011
Molecular Basis of Bacterial Outer Membrane Permeability Revisited
2003 Standout
Rational HIV Immunogen Design to Target Specific Germline B Cell Receptors
2013 StandoutScienceNobel
Klebsiella pneumoniae: Going on the Offense with a Strong Defense
2016 Standout
Synthetic double-stranded RNA induces innate immune responses similar to a live viral vaccine in humans
2011 StandoutNobel
Development of antibodies against tetravalent meningococcal polysaccharides in revaccinated complement-deficient patients
2000
Inhibition of Pneumococcal Adherence to Human Nasopharyngeal Epithelial Cells by Anti-PsaA Antibodies
2003
Characterization of Colony Morphology Variants Isolated fromStreptococcus pneumoniaeBiofilms
2006
Age-DependentNeisseria meningitidisSerogroup C Class-Specific Antibody Concentrations and Bactericidal Titers in Sera from Young Children from Montana Immunized with a Licensed Polysaccharide Vaccine
1998
Biofilm-Related Infections: Bridging the Gap between Clinical Management and Fundamental Aspects of Recalcitrance toward Antibiotics
2014 Standout
Immunobiology of Dendritic Cells
2000 Standout
Lipopolysaccharide Endotoxins
2002 Standout
Vaccination in the Neonatal Period and Early Infancy
2000
2013 IDSA Clinical Practice Guideline for Vaccination of the Immunocompromised Host
2013 Standout
ProJuvant™ (Pluronic F127®/chitosan) enhances the immune response to intranasally administered tetanus toxoid
2001
γ3 Gene-Disrupted Mice Selectively Deficient in the Dominant IgG Subclass Made to Bacterial Polysaccharides. II. Increased Susceptibility to Fatal Pneumococcal Sepsis Due to Absence of Anti-Polysaccharide IgG3 Is Corrected by Induction of Anti-Polysaccharide IgG1
2002
Chitosan Chemistry and Pharmaceutical Perspectives
2004 Standout
Insertion Sequence 1515 in the ply Gene of a Type 1 Clinical Isolate of Streptococcus pneumoniae Abolishes Pneumolysin Expression
2007 StandoutNobel
Immunochemical Properties of the Staphylococcal Poly- N -Acetylglucosamine Surface Polysaccharide
2002
Correlates of Protection Induced by Vaccination
2010 Standout
Works of L. Pais being referenced
Correlation of Opsonophagocytosis and Passive Protection Assays Using Human Anticapsular Antibodies in an Infant Mouse Model of Bacteremia forStreptococcus pneumoniae
1999
Reduction in Functional Antibody Activity Against Streptococcus pneumoniae in Vaccinated Elderly Individuals Highly Correlates with Decreased IgG Antibody Avidity
1999
Primary Human Immune Response to Neisseria meningitidis Serogroup C in Interleukin-12--Treated Severe Combined Immunodeficient Mice Engrafted with Human Peripheral Blood Lymphocytes
1997
Immune Responses of Splenectomized Trauma Patients to the 23-Valent Pneumococcal Polysaccharide Vaccine at 1 versus 7 versus 14 Days after Splenectomy
1998
Induction of Immunologic Memory in Gambian Children by Vaccination in Infancy with a Group A plus Group C Meningococcal Polysaccharide-Protein Conjugate Vaccine
1997
Duration of Antibody Response after Meningococcal Polysaccharide Vaccination in US Air Force Personnel
1994
A Trial Of A Group A Plus Group C Meningococcal Polysaccharide-Protein
1995
Safety and immunogenicity of meningococcal A and C polysaccharide conjugate vaccine in adults
1994
Determination of parallelism and nonparallelism in bioassay dilution curves
1994
Assignment of Neisseria meningitidis serogroup A and C class-specific anticapsular antibody concentrations to the new standard reference serum CDC1992
1995
Standardization of an opsonophagocytic assay for the measurement of functional antibody activity against Streptococcus pneumoniae using differentiated HL-60 cells
1997
Multicenter comparison of Neisseria meningitidis serogroup C anti-capsular polysaccharide antibody levels measured by a standardized enzyme-linked immunosorbent assay
1994